236 related articles for article (PubMed ID: 9686344)
1. The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.
Tuchman M; Morizono H; Rajagopal BS; Plante RJ; Allewell NM
J Inherit Metab Dis; 1998; 21 Suppl 1():40-58. PubMed ID: 9686344
[TBL] [Abstract][Full Text] [Related]
2. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
Tuchman M
Hum Mutat; 1993; 2(3):174-8. PubMed ID: 8364586
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.
Tuchman M; Morizono H; Reish O; Yuan X; Allewell NM
J Med Genet; 1995 Sep; 32(9):680-8. PubMed ID: 8544185
[TBL] [Abstract][Full Text] [Related]
4. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
Climent C; Rubio V
Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
[TBL] [Abstract][Full Text] [Related]
5. 'Late onset' ornithine transcarbamylase deficiency: function of three purified recombinant mutant enzymes.
Morizono H; Listrom CD; Rajagopal BS; Aoyagi M; McCann MT; Allewell NM; Tuchman M
Hum Mol Genet; 1997 Jun; 6(6):963-8. PubMed ID: 9175746
[TBL] [Abstract][Full Text] [Related]
6. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
Tuchman M; Jaleel N; Morizono H; Sheehy L; Lynch MG
Hum Mutat; 2002 Feb; 19(2):93-107. PubMed ID: 11793468
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and kinetic characterization of wild-type human ornithine transcarbamylase and a recurrent mutant that produces 'late onset' hyperammonaemia.
Morizono H; Tuchman M; Rajagopal BS; McCann MT; Listrom CD; Yuan X; Venugopal D; Barany G; Allewell NM
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):625-31. PubMed ID: 9065786
[TBL] [Abstract][Full Text] [Related]
8. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.
McCullough BA; Yudkoff M; Batshaw ML; Wilson JM; Raper SE; Tuchman M
Am J Med Genet; 2000 Aug; 93(4):313-9. PubMed ID: 10946359
[TBL] [Abstract][Full Text] [Related]
9. Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families.
Yoo HW; Kim GH; Lee DH
J Inherit Metab Dis; 1996; 19(1):31-42. PubMed ID: 8830175
[TBL] [Abstract][Full Text] [Related]
10. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene.
Yamaguchi S; Brailey LL; Morizono H; Bale AE; Tuchman M
Hum Mutat; 2006 Jul; 27(7):626-32. PubMed ID: 16786505
[TBL] [Abstract][Full Text] [Related]
11. Missense mutations in codon 225 of ornithine transcarbamylase (OTC) result in decreased amounts of OTC protein: a hypothesis on the molecular mechanism of the OTC deficiency.
García-Pérez MA; Climent C; Briones P; Vilaseca MA; Rodés M; Rubio V
J Inherit Metab Dis; 1997 Nov; 20(6):769-77. PubMed ID: 9427144
[TBL] [Abstract][Full Text] [Related]
12. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.
Matsuda I; Tanase S
Am J Med Genet; 1997 Sep; 71(4):378-83. PubMed ID: 9286441
[TBL] [Abstract][Full Text] [Related]
13. Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism.
Tuchman M; Holzknecht RA; Gueron AB; Berry SA; Tsai MY
Pediatr Res; 1992 Nov; 32(5):600-4. PubMed ID: 1480464
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.
Bisanzi S; Morrone A; Donati MA; Pasquini E; Spada M; Strisciuglio P; Parenti G; Parini R; Papadia F; Zammarchi E
Mol Genet Metab; 2002 Jun; 76(2):137-44. PubMed ID: 12083811
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy and molecular studies in ornithine transcarbamylase deficiency novel mutation c.802A>G in exon 8 (p.Met268Val).
Jamroz E; Paprocka J; Sokół M; Popowska E; Ciara E
Neurol Neurochir Pol; 2013; 47(3):283-9. PubMed ID: 23821427
[TBL] [Abstract][Full Text] [Related]
16. Site specific screening for point mutations in ornithine transcarbamylase deficiency.
Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A
J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535
[TBL] [Abstract][Full Text] [Related]
17. Screening for gene deletions and known mutations in 13 patients with ornithine transcarbamylase deficiency.
Suess PJ; Tsai MY; Holzknecht RA; Horowitz M; Tuchman M
Biochem Med Metab Biol; 1992 Jun; 47(3):250-9. PubMed ID: 1627356
[TBL] [Abstract][Full Text] [Related]
18. OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.
Lee JH; Kim GH; Yoo HW; Cheon CK
Pediatr Neurol; 2014 Sep; 51(3):354-359.e1. PubMed ID: 25011434
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
Choi JH; Lee BH; Kim JH; Kim GH; Kim YM; Cho J; Cheon CK; Ko JM; Lee JH; Yoo HW
J Hum Genet; 2015 Sep; 60(9):501-7. PubMed ID: 25994866
[TBL] [Abstract][Full Text] [Related]
20. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.
Nishiyori A; Yoshino M; Kato H; Matsuura T; Hoshide R; Matsuda I; Kuno T; Miyazaki S; Hirose S; Kuromaru R; Mori M
Hum Genet; 1997 Feb; 99(2):171-6. PubMed ID: 9048915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
